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This review covers the literature published in 2004 for marine natural products, with 693 
citations (491 for the period January to December 2004) referring to compounds isolated 
from marine microorganisms and phytoplankton, green algae, brown algae, red algae, 
sponges, coelenterates, bryozoans, molluscs, tunicates and echinoderms. The emphasis is 
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on new compounds (716 for 2004), together with their relevant biological activities, 
source organisms and country of origin. Biosynthetic studies (8), and syntheses (80), 
including those that lead to the revision of structures or stereochemistries, have been 
included. 
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Previous reviews in this series, published in 2003 and 2004, noted the passing of D. John 
Faulkner and Paul J. Scheuer, and acknowledged their contributions to the field of marine 
natural products. Sadly, we now have to note the death of Professor Kenneth L. Rinehart 
in June 2005. Professor Rinehart had an academic career at the University of Illinois that 
spanned nearly five decades (1954-2001). Rinehart, like Faulkner and Scheuer, was a 
pioneer in the study of natural products with significant contributions in the application 
of mass spectrometry to the solving of natural product structures and the emphasis placed 
on the search for bioactive compounds sourced from marine organisms. Professor 
Rinehart pioneered the use of bioassays in the field during collecting expeditions, thus 
identifying species that should be recollected in larger amounts while still at the site of 
collection. Lasting contributions from Professor Rinehart will be from his work on the 
ecteinascidins and didemnins, two of the still relatively few marine natural products in 
advanced stages of clinical trials (Yondelis™ and Aplidine™).  
This review is of the literature for 2004 and describes 716 new compounds from 
259 articles, numbers that have increased by ~10% from those of each of the past few 
years. As in previous reviews, we show structures only for new compounds, or for 
previously reported compounds where there has been a structural revision or a newly 
established stereochemistry. Previously reported compounds for which first syntheses or 
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In 2004 a larger than customary number of reviews were published covering many 
different aspects of marine natural products, with two reviews1,2 giving overall coverage 
of the 2003 literature. Several reviews describe work derived from regional collections, 
including Southern Africa,3 the Japanese coasts with emphasis on drug leads from marine 
invertebrates,4 ecosystem comparisons in New Caledonia,5 cytotoxic natural products 
from Taiwan,6 bioactive compounds from Brazil,7 diterpenes from Dictyotacean brown 
algae from the tropical Atlantic American region,8 and the efforts of Faulkner, Scheuer, 
Paul and the NCI in Palau.9 
Reviews with an ecological and/or antifouling focus include an account of 
biogenic compounds from marine algae with potential as antifouling agents,10 a general 
discussion of biofouling and antifouling,11 a review of the recent literature on marine 
chemical ecology,12 an account of chemical defense strategies of marine organisms,13 and 
some insights into the antimicrobial defenses of selected marine invertebrates.14 There 
have been three articles that explore the nature of immune systems in various phyla, 
including marine invertebrates.15,16,17 A somewhat speculative article compares selected 
marine and non-marine toxins, raising issues such as convergence and the role of 
symbiotic organisms.18   
Synthetic efforts on marine natural products continue to expand, with reviews 
covering a variety of topics including trans-fused polycyclic ethers,19 the convergent 
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syntheses of polycyclic ethers,20 the use of Suzuki-Miyaura cross-couplings for 
polycyclic ethers,21 and the total syntheses of oxazole-containing natural products.22 
Several reviews focus on studies on compounds from specific types of organisms, 
such as cytotoxic metabolites from marine algae,23 anticoagulants from marine algae,24 
metabolites of marine-derived fungi,25 antimicrobials and antifungals from marine 
microorganisms,26 toxins from microalgae,27 enzyme inhibitors from marine microbes,28 
glycosides from sea cucumbers,29 medicinal and pharmaceutical products from 
macroalgae,30 bioactive polypeptides from Anemonia sulcata,31 metabolites from several 
species of sponges of the genus Plakortis32 and specifically from Plakortis simplex,33 
peptide and peptide-like pheromones and kairomones from crustaceans,34 toxins from 
Northern Adriatic mussels,35 metabolites from the gorgonian corals of the genus 
Junceella,36 and metabolites from symbiotic bacteria.37 
A broad range of bioactivities of marine natural products is reviewed in several 
articles, including marine pharmacology in 2000,38 the merging of the potential of 
microbial genetics with biological and chemical diversity,39 drugs and cosmetics from the 
sea,40 unconventional natural sources for future drug discovery,41 new structures and 
bioactivities for small-molecule natural products,42 and marine natural products and 
related compounds in clinical and advanced preclinical trials.43 
Treatments for specific disease types is the subject of several reviews including 
the search for new candidates for cancer chemotherapy from natural products,44 
antitumour and cytotoxic compounds reported in 2001-2,45 mechanism-targeted discovery 
of antitumour marine natural products,46 antiviral marine natural products,47 antifungal 
compounds from marine organisms,48 and natural antimycobacterial metabolites.49 
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Specific compound classes are reviewed in antimicrobial peptides from marine 
invertebrates,50 bioactive peptides from marine sources,51 mycosporine-like amino acids,52 
simple indole alkaloids and those with a nonrearranged monoterpenoid unit,53 bioactive 
alkaloids,54 bisindole alkaloids from sponges,55 quinolizidine alkaloids from marine 
sources,56 purines from marine organisms,57 siderophores from marine microorganisms,58 
secosteroids of marine origin (1972-2004),59 biologically active natural glycosides,60 
drimane sesquiterpenoids (1990-2002),61 diterpenoids (2002),62 diterpenoids (2003),63 
organohalogen compounds,64 marine isocyanides and related compounds,65 and allenic 
compounds.66 
Research on specific compounds is reviewed in articles on discodermolide,67 
curacin A,68 agelasphin KRN7000,69 ecteinascidin 743, aplidine and kahalalide F,70,71 
amphidinolides (1986-2003),72 shark-repelling saponins mosesins and pavoninins,73 
lamellarins,74 and the bisindole alkaloids dragmacidins and hamacanthins.75 
A brief review on “Drugs from the Sea – Who are the producers?” explores the 
hypothesis that microorganisms, either by way of ingestion or as symbionts, are the true 
source of bioactive compounds from marine invertebrates.76 Two reviews on the use of 
mass spectrometry in peptidomics77 and analysis of marine toxins78 should be of general 
interest. The Marinlit database79 continues to be updated and has again been used as the 
basis for the preparation of this present review. 
 
3 Marine Microorganisms and phytoplankton  
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 Increasingly, the field of marine microbes is becoming a focal point for research 
and rising numbers of novel compounds continue to be identified. An actinomycete, 
Micromonospora sp. obtained from Didemnum proliferum (Shishijima Is., Japan), 
produced the dibenzodiazepine alkaloid, diazepinomicin 1, which exhibited modest 
antimicrobial activity against selected Gram-positive bacteria.80 Gutingimycin 2 is a 
highly polar trioxacarcin derivative from a Streptomyces species isolated from sediment 
(Laguna de Terminos, Gulf of Mexico).81 The absolute configuration was determined by 
X-ray analysis.82 The same Streptomyces species81 also yielded trioxacarcins D–F 3–5, in 
addition to the known trioxacarcins A–C.83,84,85 The structures and absolute 
configurations of the new trioxacarcins followed from the X-ray analysis of gutingimycin 
2 and the known stereochemistry of L-trioxacarcins A and B.85 The trioxacarcins and 
gutingimycin 2 exhibited strong antibacterial activity against a range of test organisms. 
The antitumour activity of trioxacarcin D 3 was similar to that previously reported for 
trioxacarcins A–C,83,84,85 while trioxacarcin A and trioxacarcin D 3 were also potently 
antiplasmodial.86 S. acrimycini, isolated from sediment (São Sebastião channel, Brazil), 
provided two dipeptide derivatives, 8-amino-[1,4]diazonane-2,5-dione 6 and leucyl-4-
hydroxyproline 7.87 A cultured Nereus™ strain of S. aureoverticillatus isolated from 
marine sediment (source not given) produced a macrocyclic lactam, aureoverticillactam 
8, possessing moderate activity against human tumour cell lines. Some stereochemistry 
(2E,6E) could be determined, but other olefins could not be assigned due to spectral 
overlap.88 Two caprolactones 9 and 10 were produced from a Streptomyces species 
(mangrove sediment, Papua New Guinea). The proposed structures were based on GCMS 
experiments and proven by synthesis, while the absolute configurations of 9 and 10 were 
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established using chiral GC to compare the natural and synthetic stereoisomers. 
Compounds 9 and 10 displayed moderate phytotoxicity and concentration-dependent 
inhibition of human cancer cell lines, with concomitant low general cytotoxicity.89 A 
Bacillus species obtained from mud near the Arctic pole yielded three cyclopeptides, 
mixirins A–C 11–13. The absolute stereochemistries of the amino acid residues were 
determined (Marfey’s), but not those of the fatty acid residues. The mixirins A–C 
inhibited the growth of human colon tumour cells (HCT-116).90 Petrobactin sulfonate 14, 
along with petrobactin,91 was isolated from the oil-degrading marine bacterium 
Marinobacter hydrocarbonoclasticus,91,92 and is the first marine siderophore containing a 
sulfonated 3,4-dihydroxy aromatic ring. The structure of petrobactin sulfonate was 
elucidated from spectral data, resulting in a revision of the NMR assignments for 
petrobactin.93 An actinomycete, Verrucosispora sp. (deep sediment, Sea of Japan), 
yielded the abyssomicins B–D 15–17, whose structures and relative stereochemistries 
were supported by X-ray analyses. The absolute stereochemistry of abyssomicin D 17 
was determined (Mosher and Helmchen methods) and, through structural analogy, 
assumed to be the same for abyssomicins B 15 and C 16.94 Abyssomicin C 16 was 
identified as an inhibitor of the pathway between chorismic and para-aminobenzoic acids 
and was strongly active against Gram-positive bacteria.95 Helquinoline 18, and the N-
acetylkynuramine 19, were produced by a North Sea bacterium Janibacter limosus. 
Helquinoline displayed moderate activity against B. subtilis, Streptococcus 
viridochromogenes and Staphylococcus aureus.96 Two cyclic peptides 20 and 21 were 
isolated from a bacterial Ruegeria species associated with cell cultures of a sponge 
Suberites domuncula (Gulf of Naples, Italy).97 Two further peptides from the culture 
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were known synthetic compounds,98,99 but isolated for the first time from nature. A 
known peptide100 and a new diastereoisomer 22 were also obtained, in addition to a 
peptide first reported from rabbit skin tissue.101 Cyclopeptides 20 and 21 exhibited 
moderate activity against B. subtilis.102 Two cyclodepsipeptides, petrosifungins A 23 and 
B 24, have been isolated from Penicillium brevicompactum derived from a sponge 
Petrosia ficiformis (Elba, Italy). The absolute configurations of the amino acids were 
determined (Marfey’s).103 A mixed culture of two P. corylophilum strains, (deep water 
sediment, Fiji/Matuka), provided the known fungal pigments anserinones A and B104 
along with three other pentaketides, (+)-formylanserinone B 25, (–)-epoxyserinone A 26 
and (+)-epoxyserinone A 27. Two further minor constituents of the extract, 
hydroxymethylanserinone B 28 and deoxyanserinone B 29, were isolated but not 
completely purified. The relative stereochemistries of 25 and 26 were determined (NOE 
experiments and molecular mechanics calculations), but the stereochemistry of (+)-
formylanserinone B 25105 was subsequently revised from (9S) to (9R) based on 
recognition of discrepancies in published data.104,106 Similarly, the structure of (–)-
epoxyserinone A 26 has been clarified as the structure was incorrectly drawn in the 
original report.105 The revised stereochemistry for 25 requires the absolute 
stereochemistry of 26 to be (2R,3S,4S,9R).107 Anserinone B and (+)-formylanserinone B 
25 were the most active against a range of tumour cell lines.105 P. citrinum, isolated from 
a red alga Actinotrichia fragilis (Okinawa, Japan), was the source of citrinadin A 30 that 
displayed modest cytotoxicity against L1210 and KB cell lines.108 A Penicillium species, 
from a sponge Axinella verrucosa ( Elba, Italy), produced the known compound 
communesin B109 and the new congeners communesins C 31 and D 32. Communesins B–
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D exhibited moderate antiproliferative activity against several human leukemia cell lines 
and were active against brine shrimp.110 A mussel Mytilus edulis (Toyama Bay, Japan 
Sea) was the source of an Aspergillus species that yielded a polyketide, aspermytin A 33, 
with the absolute configuration being deduced from the CD spectrum. Aspermytin A 33 
induced neurite outgrowth in rat pheochromocytoma cells.111 Golmaenone 34, a 
diketopiperazine alkaloid, was obtained from an Aspergillus species isolated from a red 
alga Lomentaria catenata (Ulsan City, Korea). The absolute stereochemistry was 
established (Marfey’s) as were significant radical scavenging and UV-A protecting 
properties.112 A. pseudodeflectus, isolated from an alga Sargassum fusiform (Miura 
Peninsula, Japan), was the source of pseudodeflectusin 35, an isochroman cytotoxic 
against human cancer cell lines.113 A diketopiperazine dimer 36 was obtained from a 
marine-derived A. niger supplied by the Australian Institute of Marine Sciences, and the 
absolute stereochemistry determined (chiral HPLC).114 A. niger, isolated from a sponge 
Axinella damicornis (near Elba, Italy), yielded seven metabolites; the bicoumanigrin 37, 
the structurally unusual 4-benzyl-1H-pyridin-6-one derivatives aspernigrins A 38 and B 
39 and the pyranonigrins A–D 40–43, which contain the unprecedented pyrano[3,2-
b]pyrrole skeleton. The absolute configurations of aspernigrin B 39 and pyranonigrin A 
40 were established by quantum chemical calculations of the CD spectra. Also isolated 
was the known fungal pigment cycloleucomelone,115,116 which was moderately cytotoxic 
against human cancer cell lines in vitro, while aspernigrin B 39 was established as 
strongly neuroprotective.117 Cultivated mycelium of A. flavipes, isolated from a sea 
anemone Anthopleura xanthogrammica (Qingdao Bay, eastern China Sea), produced two 
cerebroside analogues, flavicerebrosides A 44 and B 45, with moderate activities against 
 11 
the KB cell line.118 Aigialus parvus, isolated from mangrove wood (Thailand), provided 
the ketene acetal aigialone 46 and the spiroacetal aigialospirol 47. X-ray analysis of 46 
established the relative stereochemistry only.119 The moderately cytotoxic oxopiperazine 
metabolites, gliocladins A–C 48–50, and glioperazine 51 were isolated from a strain of 
Gliocladium species separated from a sea hare Aplysia kurodai (Kata coast, Japan). 
Relative stereochemistries at all centres, except for C-3 in 48 and 49 and for C-8 in 51, 
were determined (NOESY).120 Four cytotoxic diterpene glycosides, virescenosides R–U 
52–55, were isolated from Acremonium striatisporum originating from a holothurian 
Eupentacta fraudatrix (Kitovoe Rebro Bay, Sea of Japan).121 The stereochemistry of C-
13 in 55 was determined by comparison against known compounds.122 Apiospora 
montagnei, isolated from the inner tissue of an alga Polysiphonia violacea (North Sea 
near Helgoland), was the source of myrocin A 56, apiosporic acid 57, methyl 9-
hydroxyhexylitaconate 58 and the (–)-enantiomer 59 of the known (+)-hexylitaconic 
acid.123,124,125 Five leptosins O–P 60–64 were obtained from a Leptosphaeria species, 
originally separated from Sargassum tortile (Tanabe Bay, Japan),126 but structural and 
absolute stereochemistry determinations were performed on the derived acetates. 
Leptosins O 60 and P 61 exhibited significant cytotoxicity against P388 cells while 
leptosins O 60 and S 64 were moderately cytotoxic to 39 human tumour cell lines.127 
Emericella variecolor, (marine sediment, Gokasyo Gulf, Japan), provided two new 
sesterterpenes, 6-epi-ophiobolin G 65 and 6-epi-ophiobolin N 66 along with six 
previously reported ophiobolins. All isolated compounds were cytotoxic against a 
neuroblastoma cell line.128 The modestly cytotoxic cyclic dipeptides rostratins A–D 67–
70 were isolated from Exserohilum rostratum, a fungal strain associated with a marine 
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cyanobacterial mat (Lanai, Hawaii). Absolute configurations of the rostratins were 
determined (Mosher’s).129 Peribysins A–D 71–74, from a strain of Periconia byssoides 
originating from Aplysia kurodai,130 are eremophilane sesquiterpenoids of which 73 and 
74 represent a new class of furanofuran, and are potent inhibitors of the adhesion of HL-
60 cells to HUVEC, with 74 being the most active.131 An eremophilane sesquiterpene, 
7H239-A 75, was obtained from a xylariaceous fungus isolated from a Nypa (mangrove) 
palm frond (Kuala Selangor, Malaysia) and was cytotoxic towards a variety of cancer cell 
lines, with some selectivity for the CCRFCEM leukemia line.132 The diterpene phomactin 
H 76, with a novel skeleton including an oxepane moiety, was obtained from an 
unidentified surface fungus isolated from a brown alga Ishige okamurae (Tateishi, 
Japan). The structure and relative stereochemistry were determined by X-ray analysis.133 
Two halogenated alkenoates, 77 and 78 were isolated from an unidentified surface fungus 
of a red alga Gracillaria verrucosa (Jinha, Korea).134 A total synthesis, using a 
Cr(II)/Ni(II) macrocyclisation, has been reported135 for racemic phomactin G, from a 
marine fungal Phoma species.136 A Cladosporium species from a brown alga 
Actinotrichia fragilis (Okinawa, Japan), produced two cytotoxic macrolides, sporiolides 
A 79 and B 80. Sporiolide A 79 was also moderately antifungal against a range of 
organisms, while both sporiolides were active against Micrococcus luteus.137 Fuscoatrol 
A 81, a caryophyllene sesquiterpene, was isolated from Humicola fuscoatra associated 
with an unidentified colonial ascidian (Shikotan Is., Kuril Isles) with the structure being 
confirmed by X-ray analysis. Fuscoatrol A 81 displayed moderate antimicrobial activity 
and was cytotoxic against sea urchin eggs.138 Lyngbya majuscula (Hector’s Bay, Jamaica) 
was the source of three lipopeptides, jamaicamides A–C 82–84. Structural elucidation 
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included the use of the Accordion 1,1-ADEQUATE experiment.139 This experiment 
detects 1H-13C-13C spin systems for a wide range of 13C-13C coupling values and permits 
unequivocal distinction between 2- and 3-bond HMBC correlations. Only the C-23 
stereochemistry of jamaicamide A 82 could be determined (Marfey’s). Biosynthetic 
experiments suggested that the jamaicamides result from alternating PKS and NRPS 
assembly units, confirmed through cloning and identification of the biosynthetic gene 
cluster. The jamaicamides displayed cytotoxic, sodium channel blocking and 
ichthyotoxic activities.140 Eleven chlorinated lipids, taveuniamides A–K 85–95, were 
isolated from two mixed samples of L. majuscula and Schizothrix sp. (Taveuni Is., Fiji). 
Taveuniamides F 90, G 91 and K 95 exhibited relatively potent brine shrimp toxicity.141 
From a total synthesis of kalkitoxin and its congeners, the absolute stereochemistry of 
this potent neurotoxin isolated from L. majuscula142 could be assigned as 
(3R,7R,8S,10S,2'R).143 Kalkitoxin, from a second total synthesis, exhibited potent activity 
against HCT-116.144 A Symploca species (Fingers Reef, Guam) was the source of two 
cytotoxic compounds, micromide 96 and guamamide 97. Chiral HPLC and chemical 
derivatisation followed by comparison with synthetic standards established the absolute 
stereochemistry of 96.145 Isolation of 8-hydroxy-3,5-dimethyl-isochroman-1-one146 from 
a mangrove fungus (coastal South China Sea) is the first report of this compound from a 
marine source.147 A symbiotic dinoflagellate Symbiodinium species, from an acoel 
flatworm Amphiscolops species (source not given), produced the amphoteric iminium 
compound symbioimine 98. The absolute stereochemistry was determined by X-ray 
analysis. Symbioimine 98 inhibited osteoclastogenesis of the murine monocytic cell line 
RAW264 and therefore has potential for use as an antiresorptive for prevention and 
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treatment of osteoporosis in postmenopausal women.148 The cytotoxic 25-membered 
macrolide amphidinolide C2 99 was obtained from a dinoflagellate Amphidinium species 
isolated from an acoel flatworm Amphiscolops species (Sunabe, Okinawa).149 Structural 
elucidation of (+)-amphidinolide A 100, also from an Amphidinium species,150,151 has 
been completed through a combination of NMR analysis and total synthesis.152 
Amphidinolide H153 attenuated actin depolymerisation induced by diluting F-actin and 
enhanced the binding of phalloidin to F-actin and is therefore a useful tool for analyzing 
actin-mediated cell function.154 A total synthesis of amphidinolide W 101, a 12-
membered macrolide isolated from an Amphidinium species,155 has been completed with 
revision of the C-6 stereochemistry.156 A total synthesis of amphidinolide X157 has also 
been reported.158 A dinoflagellate Amphidinium species, originally isolated from the 
surface wash of seaweeds (Lingshui Bay, Hainan Province, China), was the source of the 
potent cytotoxin lingshuiol 102.159 The same culture yielded two further lingshuiols, A 
103 and B 104.160 Two strains of a dinoflagellate Protoceratium cf. reticulatum (Sanriku, 
Iwate, Japan) were the source of four potent antitumour compounds, protoceratins 1–4. 
Protoceratin 1 was identical to the shellfish toxin 2-homoyessotoxin,161 while 
protoceratins 2–4 105–107 were determined to be the di-, mono- and tri-arabinosides of 
2-homoyessotoxin respectively.162 A Symbiodinium species, isolated in the free-living 
state from a Hawaiian tide pool, gave the polyhydroxy metabolite zooxanthellamide B 
108, a δ-lactone analogue of zooxanthellamide A163 which had previously been obtained 
from the same dinoflagellate.164 Several Symbiodinium strains obtained from different 
researchers around Japan produced zooxanthellactone 109. The original strain used for 
the production was isolated from the foraminifer, Amphisorus hemprichii. The absolute 
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stereochemistry of zooxanthellactone 109, which was modestly cytotoxic against two 
human squamous cell carcinomas, was also established.165 The polyether brevenal 110, 
obtained from laboratory cultures of Karenia brevis as well as collections off the west 
coast of Florida during a red tide, competes with brevetoxin for a site associated with the 
voltage-sensitive sodium channel thus protecting fish from the neurotoxic effects of 
brevetoxin exposure. Brevenal may have utility as a model compound for the 
development of therapeutics to prevent, or reverse intoxication in red tide exposures.166 A 
study in rats using short-term inhalation exposure to brevetoxin 3167 suggested that the 
immune system may be a target of toxicity following brevetoxin inhalation.168 The rapid 
effects of brevetoxin-2169 and saxitoxin170 on embryonic murine frontal cortex neuronal 
networks on microelectrode arrays have been reported.171 NMR studies on two synthetic 
diastereomeric models corresponding to the CDE/FG ring of prymnesins,172,173 suggested 
that the earlier stereochemical assignment of the E/F ring juncture in the prymnesins 
needs to be revised.174 A total synthesis of oscillarin 111, an antithrombotic peptide from 
Oscillatoria agardhii,175 has been achieved, confirming the absolute stereochemistry 
proposed and correcting the structure of a subunit to the Δ3-pyrroline-containing unit 
shown. Bioassays confirmed that 111 is a potent thrombin inhibitor while the originally 
assigned structure is inactive. An X-ray analysis of a ternary complex between oscillarin 
and α-thrombin has been reported.176 Synthetic (1S,2S) grenadamide had equal but 
opposite optical rotation from natural grenadamide from Lyngbya majuscula,177 which is 
therefore the (1R,2R)-enantiomer 112.178  Both enantiomers of xestodecalactone A179 
have been synthesised, and CD and chiral HPLC comparisons have confirmed the (R)-
configuration for the natural product.180 Using inexpensive starting materials, concise 
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total syntheses of the maculalactones A,181 B182 and C,182 from a cyanobacterium 
Kyrtuthrix maculans, have been achieved. Results from optical rotation measurement, 
chiral HPLC and NMR spectroscopy in the presence of a chiral shift reagent established 
that natural maculalactone A is present in K. maculans as a partially racemic mixture.183 
Total synthesis of the Bacillus laterosporus polyketide antibiotics basiliskamide A and 
B184 confirmed the assignment of absolute configuration as (7S,8S,9R,10S).185 The first 
total synthesis of (+)-phomopsidin, a microtubule assembly inhibitor and isolated from a 
Phomopsis species,186 has been achieved via a diastereoselective transannular Diels-Alder 
reaction.187 The total synthesis of halovir A,188 one of a series of linear, lipophilic 
peptides produced by a Scytalidium species, has been completed as part of a structure-
activity relationship study of the series.189 A one-pot multistep domino reaction from a 
starting enone of established absolute configuration was used to complete a total 
synthesis of the mangrove fungus metabolite (+)-xyloketal D.190,191 The dinoflagellate 
metabolite yessotoxin192 has been shown to induce a cyclosporin A-sensitive permeability 
transition in rat liver mitochondria and Morris Hepatoma 1C1 cells in the presence of 
permissive levels of calcium, and also induces membrane depolarisation.193 The potent 
ichthyotoxin antillatoxin from Lyngbya majuscula,194 along with three synthetic 
stereoisomers, were assessed for ichthyotoxicity and cytotoxicity in five different assay 
systems. In all assays the natural antillatoxin was the most potent.195 Euplotin C,196 a 
sesquiterpene from a marine ciliate protist Euplotes crassus, displayed moderate activity 
against the protozoa Leishmania major and L. infantum and mild activity against Candida 
albicans.197 An assay for inhibitors of lymphocyte function-associated molecule 
1/intercellular cell adhesion molecule-1 (LFA-1/ICAM-1) mediated cell-cell adhesion 
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was used to identify new pharmacologically active compounds from marine 
cyanobacteria and algae.198 Six of the sixty marine natural products tested significantly 
inhibited LFA-1/ICAM-1 mediated cell adhesion after primary and secondary testing. 
These compounds were cymathere aldehyde,199 microcolins B200 and D,198 
avrainvilleol,201 cymopol202 and hormothamnione diacetate.203,204,205 The stereochemistry 
of a cyclisation product, and results of incorporation experiments with [1-13C]- and [1,2-
13C2]-acetates, were used to propose the course of geranylgeranyl diphosphate cyclisation 
in the biosynthesis of the phomactins206,207,208,136 from a marine fungal Phoma species.209 
Incubation of a diatom Rhizosolenia setigera with [1-13C]-acetate indicated that the 
polyunsaturated monocyclic sesterterpene and triterpene metabolites are produced 
predominantly via the mevalonate pathway.210 
 
4 Green algae 
 
Very few new secondary metabolites from green algae have been reported. Capisterones 
A 113 and B 114 are triterpene sulfate esters isolated from Panicillus capitatus (Cat Cay, 
Bahamas). Both compounds exhibited potent antifungal activity against the marine algal 
pathogen Lindra thallasiae.211 
 
5 Brown algae 
 
As noted in previous reviews, terpenes and polyphenolic compounds are the predominant 
metabolite classes found in brown algae. A sample of Eisenia bicyclis, a very common 
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Pacific-coast Japanese species, was purchased from a Japanese company and yielded a 
new phloroglucinol derivative 115, and two known phloroglucinols, eckol212 and 
dieckol.213,214 All three compounds inhibited glycation and α-amylase, so may have an 
effect on complications of diabetes.215 Phloroglucinol216 and the derivatives 
eckstolonol,217 eckol,212 phlorofucofuroeckol A218 and dieckol,213 isolated from Ecklonia 
stolonifera are tyrosinase inhibitors.219 Five meroditerpenes, amentol chromane diacetate 
116, cystoseirone diacetate 117, preamentol triacetate 118, 14-epi-amentol triacetate 119 
and 14-methoxyamentol chromane 120 were obtained from a Cystoseira species (Canary 
Islands).220 Two cytotoxic trihydroxylated diterpenes based on 12-
hydroxygeranylgeraniol, 121 and 122, were isolated from Bifurcaria bifurcata (Atlantic 
coast of Morocco). The absolute configuration at C-12 in both compounds was 
established (Mosher’s), but the stereochemistries of C-6 in 121 and C-7 in 122 could not 
be unambiguously determined.221 Scytosiphon lomentaria, cultured in deep seawater, 
produced the bisnorditerpene 123.222 The secondary metabolite composition of Dictyota 
dichotoma (Aegean Sea) and D. linearis (Chios Is., Greece), were examined and new 
diterpenes isolated; isopachydictyolal 124 from D. dichotoma and 4α-acetyldictyodial 
125 from D. linearis.223 D. dichotoma (Karachi coast in the Arabian Sea) yielded three C-
16 oxidised seco-dolastanes, dichotenols A-C 126–128.224 A new dolabelladiene 
derivative 129 and the previously isolated 10,18-diacetoxy-8-hydroxy-2,6-
dolabelladiene225 were characterised from D. pfaffii (Northeast Brazil).226 Both 
compounds showed strong anti-HSV-1 activity in vitro but little inhibition of HIV-1 
reverse transcriptase. 10,18-Diacetoxy-8-hydroxy-2,6-dolabelladiene225 was the 
antifeedant component of D. pfaffii against the sea urchin Lytechinus variegatus and 
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generalist fishes.227 The diterpenes (6R)-6-hydroxydichotoma-3,14-diene-1,17-dial, and 
the 6-acetate derivative, from D. menstrualis,228 originally isolated from D. dichotoma,229 
exhibited antiretroviral activity in vitro.228 Two glycerol derivatives, 130 and 131, were 
obtained from Sargassum parvivesiculosum (Hainan Province, China).230 The 
sesquiterpene-substituted benzoic acid, dictyvaric acid 132, was isolated from 
Dictyopteris divaricata (Shandong coast, China),231 while seven cadinane sesquiterpenes, 
133–139, were obtained from D. divaricata (Qingdao coast, China). Structures and 
absolute configurations of 133–139 were established from spectroscopic data and X-ray 
analysis of 133 and 136.232 Six dibenzyl bromophenols 140–145,233 with different 
dimerisation patterns, and two propyl bromophenol derivatives, 146 and 147,234 were 
isolated from Leathesia nana (Shandong Province, China). X-ray analysis determined 
that 145 was a racemate. Compound 142 showed moderately selective cytotoxicity, and 
140 may have been an artifact of isolation.233 Surprisingly, compound 146 was reported 
in another paper by the same authors.235 The moderately cytotoxic 
diphlorethohydroxycarmalol 148, from Ishige okamurae (Boso Peninsula, Japan),236 was 
characterised by conversion to the known nonaacetate.237 An enantioselective synthesis 
of the proposed structures for the bioactive (E)- and (Z)-usneoidones, from Cystoseira 
usneoides,238 has been completed by a convergent strategy.239 However, the spectroscopic 
data of the synthetic products differed significantly from the reported values. The 
phlorotannin derivatives 8,8'-bieckol240 and 8,4'''-dieckol,241 from Ecklonia cava (Korean 
coasts), are inhibitors of HIV-1 reverse transcriptase (RT) and protease. Both compounds 
inhibited the RT more potently than the protease and the inhibitory activity of 8,8'-
bieckol against HIV-1 RT was comparable to that of nevirapine, a reference 
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compound.242 Fucosterol243,244 was isolated from Pelvetia siliquosa and in vivo testing 
demonstrated that it is the main antidiabetic principle from P. siliquosa.245  
 
6 Red algae 
 
As for the brown algae, terpenes and polyphenolic compounds continue to be the 
predominant metabolite classes reported from red algae. Laurencia obtusa (Isla Grande, 
Panama), contained the oxygenated sesquiterpene chamigrenelactone 149.246 The 
sesquiterpene 150 and a halogenated C15 acetogenin 151, a stereoisomer of 
neoisoprelaurefucin,247 were isolated from L. obtusa (Tekirova, Turkey).248 Two 
halogenated diterpenes, 15-bromoparguer-9(11)-ene-16-ol 152 and 15-bromoparguer-7-
ene-16-ol 153, were obtained from L. nipponica (Troitsa Bay, Sea of Japan).249 Bioassay-
guided fractionation of an extract from L. intricata (Discovery Bay, Jamaica), gave the 
diterpene laurenditerpenol 154 and the absolute configuration at C-1 was established 
(Mosher’s). 154 was a potent inhibitor of hypoxia-activated hypoxia-inducible factor-1 
and of the angiogenic factor hypoxia-induced VEGF in T47D cells.250 Two 
phenylpropanoic acid derivatives, tichocarpols A 155 and B 156, were isolated from 
Tichocarpus crinitus (Katsurakoi coast of Japan). These two compounds, along with 
floridoside,251 also isolated from the alga, exhibited antifeedant activity against the sea 
urchin Strongylocentrotus intermedius.252 Inositol phosphoceramide 157 was isolated 
from Gracilaria verrucosa (Sea of Japan) and identified by GC and GCMS analysis.253 
Peyssonnelia caulifera (Yanuca Is., Fiji) was the source of two enediyne ω3 monoacyl 
glycerides, peyssonenynes A 158 and B 159, and a pyrone-containing ω3 fatty acid 
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methyl ester, peyssopyrone 160, but the instability of the peyssonenynes prevented 
complete stereochemical assignment. Both peyssonenynes displayed activity at a similar 
level in a DNA methyltransferase enzyme inhibition assay.254 Rhodomela confervoides 
(Qingdao coast, China) was the source of seven new bromophenol derivatives 161–167, 
together with two known bromophenol compounds. X-ray analysis of 161 and 162 
supported the structural assignments. The known synthetic compounds 3-bromo-5-
hydroxy-4-methoxyphenylacetic acid255 and 3-bromo-5-hydroxy-4-methoxybenzoic 
acid,256 were obtained as natural products for the first time.257 Seven brominated 
diterpenes of the parguerene and isoparguerene series isolated from Jania rubens (Red 
Sea coast of Egypt) included the novel deoxyparguerol-7-acetate 168. All the isolated 
diterpenes had anthelmintic activity and exhibited antitumour activity against Ehrlich 
ascites carcinoma in vitro with isoparguerol derivatives being slightly more effective than 
parguerol derivatives.258 The first total synthesis of (–)-presphaerene 169259 from 
Sphaerococcus coronopifolius was achieved from (R)-glyceraldehyde260 and established 
the relative and absolute stereochemistries of 169 as well as the absolute 
stereochemistries of the co-occurring sphaeroanes (+)-presphaerol,261,262 isosphaerodiene 
1263 and isosphaerodiene 2.263 The first enantioselective total synthesis of (+)-
brasilenyne264,265 was reported, starting from (S)-malic acid.266 Also reported in 2004 was 
the first total synthesis of the sesquiterpenoid (+)-palisadin B from Laurencia cf. 
palisada,267 utilising a new method for the formation of trans-anti cyclogeranyl-oxepene 
systems.268 Furoplocamioid C, prefuroplocamioid, pirene and a tetrachlorinated 
cyclohexane from Plocamium cartilagineum269 exhibited selective cytotoxicity against 
human tumour cell lines with pirene showing a specific and irreversible effect on SW480 
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cells.270 Halogenated metabolites from several species of Laurencia were tested for 
antibacterial activity against 22 strains of human pathogenic bacteria, including seven 
strains of antibiotic-resistant bacteria. Laurinterol,271 isolaurinterol,272 allo-laurinterol,273 
cupalaurenol274 and 2,3,5,6-tetrabromoindole275 displayed a wide spectrum of 
antibacterial activity against Gram-positive bacteria including methicillin-resistant 
Staphylococcus aureus, penicillin-resistant Streptococcus pneumoniae and vancomycin-
resistant Enterococcus faecalis and E. faecium. Laurinterol and allo-laurinterol were 
particularly effective.276 Studies on vanadium bromoperoxidase isolated from marine red 
algae have established it as a catalyst in the biosynthesis of brominated cyclic 




Unusual fatty acid derived metabolites are often isolated from sponges, and some motifs 
seem to be characteristic of the phylum; 2-methoxylated fatty acids are one such group of 
metabolites. A series of these compounds were synthesised, found to be active against 
mycobacteria, and proposed as a possible chemical defense mechanism in sponges.278 
Two long 2-methyl substituted fatty acids 170 and 171 were isolated as methyl esters 
from Halichondria panicea (Sea of Japan, Russia).279 A Chinese Spongia species yielded 
the ceramides spongiamines A 172 and B 173.280 Clarhamnoside 174, a glycolipid 
containing an unusual L-rhamnose unit, was isolated from the Bahamian Agelas 
clathrodes.281 The relative stereochemistry of the sugar units was determined from proton 
coupling constants determined with the use of a 13C-coupled HMQC experiment. The 
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absolute stereochemistry of the alkyl chain oxymethine of caminoside A, originally 
isolated from Caminus sphaeroconia,282 has been determined as (10R) by the preparation 
of a TPP diester of the aglycone.283 An inhibitor of bacterial proteases, pachymoside A 
175, was isolated from Pachymatisma johnstonia (Isle of Man).284 An α-glycosidase 
inhibitor, penasulfate A 176, was obtained from a Japanese Penares species using 
recycling HPLC.285 Mycale cecilia (Gulf of California, Mexico) yielded fourteen 
cytotoxic long chain pyrroles, mycalazals 3–13 177–187, and three nitrile-containing 
congeners, the mycalenitriles 1–3 188–190.286 A Korean Homaxinella species yielded 
three weakly cytotoxic butenolides, homaxinolides A–C 191–193, along with the 
moderately cytotoxic cyclopentenone, homaxinone A 194. Also isolated from the same 
collection was an unsaturated alcohol 195 previously known only as a synthetic 
intermediate.287 A pair of isomeric bisthiocyanates, thiocyanatins D1 196 and D2 197, and 
the related thiocyanate-thiocarbamates, thiocyanatins E1 198 and E2 199, were obtained as 
inseparable pairs from a South Australian Oceanapia species; all compounds were potent 
nematocides. Several related compounds were also tentatively identified by mass 
spectrometry.288 An acetylenic acid 200 has been obtained from a Chinese Cinachyrella 
australiensis.289 A Plakortis species (Canary Islands) contained plakolide A 201, a γ-
lactone that inhibits inducible nitric oxide synthase activity.290 Two isomeric cytotoxic 
trans epoxides, plakorstatins 1 202 and 2 203, were isolated from Plakortis nigra 
(Sulawesi, Indonesia).291 A Dominican Plakortis anglospiculatus provided two highly 
branched tricylic acids, spiculoic acids A 204 and B 205 which are thought to be the 
result of a Diels Alderase-catalyzed intramolecular [4+2] cycloaddition.292 A series of 
glycosphingolipids were partially characterised from four Agelas species using tandem 
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HPLC/ESIMS  and HPLC/LSIMS.293 Dideoxypetrosynol A, a polyacetylene originally 
obtained from a Petrosia species,294 induced apoptosis in human melanoma cells.295 
Manzamenone A296 was a potent inhibitor of β DNA polymerase and only weakly active 
against the α form of the enzyme.297 A lysophosphatidylcholine, originally isolated from 
Spirastrella abata,298 has been shown to increase intracellular Ca2+ concentration in 
human leukemia cells.299 Mycalazal 2 and mycalazol 11, pyrrole-containing lipids 
isolated from Mycale micranthoxea,300 have been synthesised using a Stille coupling.301 
A synthesis of (2R,5Z,9Z)-2-methoxyhexacosa-5,9-dienoic acid, from Topsentia 
roquensis,302 has been accomplished using a novel HgO mediated O-alkylation.303 A 
racemic synthesis of plakortone E 206304 has established the relative stereochemistry,305 
and an asymmetric synthesis of plakortone G 207306 defined both the relative and 
absolute stereochemistries.307 Two dimeric peroxides, dihalenaquinolides A 208 and B 
209, were isolated from a Taiwanese Petrosia elastica.308 A very potent cytotoxin, 
psymberin 210, related to the pederin family of metabolites, was obtained from a series of 
Papua New Guinean collections of Psammocinia species.309 In an independent study, a 
compound named irciniastatin A, having the same NMR characteristics as 210 but 
claiming different stereochemistry at C-8, and the keto analogue irciniastatin B 211 were 
isolated from Ircinia ramosa (Borneo).310 Four calyculin analogues, calyculin J 212, 
calyculinamide F 213, des-N-methylcalyculin A 214 and the known calyculinamide A,311 
were obtained from a Japanese Discodermia calyx. All four compounds were potent 
inhibitors of protein phosphatase 2A.312 A prokaryotic gene cluster, proposed to be 
responsible for the biosynthesis of onnamide A, has been isolated from the metagenome 
of Theonella swinhoei. The specific PKS cluster is distinct from many others by the lack 
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of an acyltransferase domain, a characteristic that it shares with the pederin gene cluster. 
The onnA cluster was found only in the chemotypes of T. swinhoei that produce 
onnamide A and the theopederins.313 In a series of five consecutive papers the large-scale 
synthesis of discodermolide is described, culminating in the production of 60 g of 
enantio-pure material.314 Discodermolide, a microtubule stabilizing agent, was originally 
isolated from a deepwater Discodermia disoluta.315 The level of commitment involved in 
this large-scale synthesis of a highly complex marine natural product is a measure of the 
importance of the field of marine natural products to medical research and the 
pharmaceutical industry. Sponges continue to be a rich source of novel and biologically 
active peptides. The dysinosins B–D 215–217, from a Queensland Lamellodysidea 
chlorea, were inhibitors of serine protease factor VIIa and thrombin.316 The microtubule-
destabilizing peptide, milnamide C 218, was obtained from an Auletta species (Papua 
New Guinea).317 Milnamide D 219, isolated from a Cymbastela species and reported in 
2003,318 was inadvertently omitted from the previous review.1 An asymmetric synthesis 
of milnamide A 220319 and the subsequent autoxidation to milnamide D established the 
relative and absolute stereochemistry of these two potent antimitotic compounds.320 
Scleritoderma nodosum (Philippines) contained the cytotoxic cyclic peptide 
scleritodermin A 221.321 Another Philippine sponge, Clathria (Thalysias) abietina, 
yielded two isomeric disulfide-bridged heptapetides, microcionamides A 222 and B 223, 
with cytotoxic and antitubercular activities.322 An unusually cyclised peptide, 
callynormine 224, isolated from Callyspongia abnormis (Kenya), represents a new class 
of heterodectic cyclic peptide, the endiamino peptides, which contain an α-amido-β-
aminoacrylamide functionality.323 Axinella carteri (Caroline Islands) yielded the 
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octapeptide cyclonellin 225.324 Kendarimide A 226, a linear peptide obtained from a 
Haliclona species (Sulawesi, Indonesia), reversed P-glycoprotein-mediated multi-drug 
resistance in mammalian cells.325 A large depsipeptide, neamphamide A 227, with potent 
cytoprotective activity against HIV-1 was isolated from a Papua New Guinean 
Neamphius huxleyi.326 Phakellistatin 13, recently isolated from Phakellia fusca,327 has 
been synthesised, confirming the natural L configuration of the tryptophan residue.328 
Phakellistatin 13 was also converted by photo-oxidation into phakellistatin 3 and 
isophakellistatin 3, both originally obtained from P. carteri.329 Miraziridine A, isolated 
from Theonella aff. mirabilis,330 has been synthesised and is an inhibitor of three classes 
of proteases.331 Callipeltin A, originally isolated from a New Caledonian Callypelta 
species,332 acts as an ionophore, increasing the contraction of vascular tissues in the 
presence of Na+ ions.333 The complex structures and often spectacular biological activity 
of sponge-derived macrolides and their related congeners provide attractive targets and 
considerable challenges to natural product and synthetic chemists alike. Examples of 
these include the two oxazole-containing macrolides neohalichondramide 228, (19Z)-
halichondramide 229 and a related ring opened compound secohalichondramide 230 
obtained from Chondrosia corticata (Guam),334 and the three cytotoxic mycalolides, 30-
hydroxymycalolide A 231, 32-hydroxymycalolide A 232, and 38-hydroxymycalolide B 
233 isolated from a Japanese Mycale magellanica.312 Latrunculeic acid 234, from 
Negombata (Latrunculia) magnifica335 (Gulf of Eilat, Red Sea), is clearly related to the 
latrunculin macrolides, isolated previously from the same sponge.336 Spongidepsin 235, 
originally isolated from a Spongia species (Vanuatu),337 has been synthesised 
independently by two groups defining both relative and absolute configurations.338,339 
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The relative stereochemistry of dictyostatin 236, originally obtained from a Spongia 
species,340 has been determined (Murata’s method), revising the original structure.341 
Two independent groups have confirmed this relative stereochemistry and absolute 
configuration by synthesis.342,343 Five antiproliferative lasonolide congeners, lasonolides 
C–G 237–241, were isolated from a Forcepia species (west coast of Florida).344 A larger 
recollection of the producing organism, Spirastrella coccinea, yielded sufficient 
spirastrellolide A 242 for further spectroscopic examination and derivative preparation. 
Originally reported with a molecular formula of C53H86O19,
345 an extensive re-analysis 
led to the determination of a new molecular formula, exchanging H3O2 for Cl, and 
structural revision (as shown). The relative stereochemistries of segments C-3–C-7, C-9–
C-24, and C-27–C-38 were established from ROESY data obtained at 800 MHz.346 The 
synthesis of a series of diastereomers of a degradation fragment of reidispongiolide A 
243, originally isolated from Reidispongia coerulea,347 has led to a reassignment of the 
relative stereochemistry of the C-7–C15 fragment.348 The potent cytotoxin 13-
deoxytedanolide, from Mycale adhaerans,349 has been shown to bind to the 60S large 
ribosomal subunit.350 Two brominated biphenyl ethers 244 and 245 were isolated from 
Phyllospongia dendyi (Palau), along with a series of related known compounds. Some of 
the known dihydroxy congeners showed inhibitory activity towards the assembly of 
microtubules.351 A tricyclic dipeptide betaine, dysibetaine PP 246, and two cyclopropane 
betaines, dysibetaines CPa 247 and CPb 248, were isolated from an aqueous extract of 
Dysidea herbacea (Yap, Micronesia).352 A Japanese Spongia species produced the 
moderately antifungal spongiacysteine 249.353 Three aromatic amino acid-derived 
alkaloids, hamigeroxalamic acid 250, hamigeramine 251, and hamigeramide 252 were 
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isolated from a Mediterranean Hamigera hamigera.354 Esmodil 253, known previously as 
a synthetic drug, has been found as a metabolite of a South Australian Raspailia 
species.355 A series of twenty new phloeodictine alkaloids 254–273, together with several 
known congeners, were obtained from Oceanapia fistulosa (New Caledonia). The 
compounds were characterised by LCMS from a complex mixture that showed 
antiplasmodial activity against chloroquine-resistant Plasmodium falciparum.356 
Alkylpyridine-derived alkaloids are a characteristic of sponges that continue to provide 
an assortment of unusual metabolites. Viscosaline 274 was obtained from Haliclona 
viscosa (Russian Arctic Ocean).357 The same sponge, but from Svalbard in the Norwegian 
Arctic, yielded haliclamines C 275 and D 276.358 Three inhibitors of histone deacetylase, 
cyclostellettamine G 277 and dehydrocyclostellettamines D 278 and E 279, were isolated 
from a Japanese Xestospongia species.359 A Brazilian Pachychalina species yielded the 
cytotoxic ingenamine G 280, the previously described cyclostellattamine G, and four new 
congeners, cyclostellattamines H, I, K and L 281–284.360 An Amphimedon species 
(Southern Japan) contained tetrahydrohalicyclamine 285 and 22-hydroxyhalicyclamine 
286, both of which inhibit the growth of mammalian cells.361 A new 
aruguspongine/xestospongine analogue, araguspongine M 287, has been described from 
Neopetrosia exigua (formerly Xestospongia exigua) from Palau.362 Hachijodine B, 
originally isolated from a Xestospongia species,363 has been synthesised, along with the 
proposed structure of ikimine B originally isolated from an unidentified sponge,364 but 
the spectra of the synthetic ikimine B did not match that of the natural product suggesting 
a possible incorrect assignment of the original structure.365 Three manzamine alkaloids 
288–290 have been isolated from an Indonesian Acanthostrongylophora species. The 
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activities of several known manzamine alkaloids as potent antiinflammatory, antifungal, 
and anti-HIV-1 agents were also reported.366 Indole-based alkaloids are well represented 
among sponge metabolites. Three further iodinated indole alkaloids, plakohypaphorines 
D–F 291–3 are reported from Plakortis simplex (Bahamas). Plakohypaphorines B–D 
have significant antihistamine activity.367 The weakly cytotoxic guanine-containing 6-
hydroxydiscodermindole 294 was obtained from Discodermia polydiscus (Bahamas).368 
An antifouling alkaloid, 8,9-dihydrobarettin 295, has been isolated from Geodia 
barretti.369 The recently reported revised structure for barettin,370 from G. baretti,371 has 
been synthesised confirming the revised structure.372 Using LCMS, barettin has been 
detected at biologically-significant concentrations in water surrounding live G. barretti 
specimens.369 An enantiospecific synthesis of the (+)-dragmacidin F has established the 
absolute configuration of the natural product as (4'S,6''S,6'''S).373 Two thiomethyl-
containing β-carbolines, dragmacidonamines A 296 and B 297, were isolated from a 
Dragmacidon species (Adaman Islands, India).374 A Thorectandra species (Palau) 
produced a β-carboline alkaloid 298 with moderate cytotoxicity.375 A series of fused 
bisindole-derived compounds 299–306 in the fascaplysilin series were isolated from 
Fascaplysinopsis reticulata (Indonesia).376 Pyrroloquinones and pyrroloiminoquinones 
are associated with sponges, particularly members of the Order Poecilosclerida. 
Zyzzyanone A 307, which is moderately cytotoxic and inhibits division of fertilised sea 
urchin eggs, was isolated from an Australian Zyzzya fuliginosa.377 Two β-D-
ribopyrroloquinoline alkaloids 308 and 309 were obtained from a South African 
Strongylodesma aliwaliensis.378 Four new discorhabdins, 3-dihydro-7,8-
dehydrodiscorhabdin C 310, 14-bromo-3-dihydro-7,8-dehydrodiscorhabdin C 311, 
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discorhabdin V 312, and 14-bromo-1-hydroxydiscorhabdin V 313 were isolated from the 
South African Tsitsikamma pedunculata. In the same article, the tsitsikammanamines A 
314 and B 315 are reported from T. favus along with 1-methoxydiscorhabdin D 316 and 
1-aminodiscorhabdin D 317 from Latrunculia bellae.379 Also isolated from L. bellae was 
discorhabdin G*, identical in structure with discorhabdin I 318 which was reported, along 
with discorhabdin L 319, from Latrunculia brevis (Argentina).380 Fortunately, some of 
the confusion over the earlier naming of the discorhabdin series has been resolved in a 
2005 review on pyrroloiminoquinones.381 Cribrostatin 7 320, a cytotoxic quinone alkaloid 
was obtained from a Petrosia species (Philippines).382 A Chinese Cinachyrella 
australiensis contained isolumichrome 321.289 Bisdemethylaaptamine 322 and the 9-O-
sulfate analogue 323 were isolated from an Indonesian Aaptos species.383 The racemic 
spiro-polycyclic aromatic alkaloid lihouidine 324, obtained from a new species of 
Suberea (Lihou reef, Coral Sea), showed cytotoxic activity.384 Syntheses of 7-methoxy-
1,6-dimethylisoquinoline385 from a Xestospongia species,386 6-hydroxy-7-
methoxyisoquinolinemethanol387 from a Haliclona species,388 and cribrostatin 6389 from a 
Cribrochalina species,390 have been completed. Renieramycin A, from a Reniera 
species,391 had antileishmanial activity.392 A Leucetta species (Papua New Guinea) 
provided spiroleucettadine 325 which showed antibacterial activity against Enterococcus 
durans.393 Leucetta chagosensis (Sulawesi, Indonesia) contained naamines F 326 and G 
327 as well as kealiinines A–C 328–330. Naamine G was strongly antifungal.394 
Monanchora unguifera (Jamaica) provided 1,8a;8b,3a-didehydro-8α-hydroxyptilocaulin 
331, together with the known 8β isomer, which co-crystallised in perfect order with an 
approximate inversion centre.395 Monanchorin 332, a new bicyclic metabolite and the 
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pentacyclic crambescidin acid 333, previously reported as the ethyl ester,396 have both 
been isolated from Monanchora ungiculata (Maldive Islands).397 Two phakellin 
alkaloids, 334 and 335, active as human lipoxygenase inhibitors, were found in an Agelas 
species (Papua New Guinea).398 An Okinawan Agelas species provided the nagelamides 
A–H 336–343 and 9,10-dihydrokeramadine 344. The nagelamides were antibacterial, 
while nagelamide G inhibited protein phosphatase 2A activity.399 A systematic analysis 
of CD spectra and Mosher acid derivatives suggested that the configuration of longamide 
A, from Agelas longissima,400 be revised to (4R).401 (±)-Sceptrin,402,403 from Agelas 
sceptrum,404 and (±)-dibromosceptrin403 from Agelas conifera,405 have both been 
synthesised. The conversion of ageliferin into sceptrin using microwave irradiation also 
revealed a possible alternative biosynthetic pathway linking the pyrrole-imidazole 
alkaloids.406 The synthesis of dehydrobatzelladine C, originally isolated from two 
Monanchora species396 has been reported.407 The first enantiospecific synthesis of 
agelastatin A, isolated from Agelas dendromorpha,408 has been achieved.409 The HIV-
active alkaloid batzelladine A, from a Batzella species,410 has been synthesised in an 
enantio-pure form.411 Crambescidin 800, originally isolated from Crambe crambe,412 
caused myelogenous leukemia cells to differentiate into erythrocytes.413 The schulzeines 
A–C 345–347 were isolated from Penares schulzei (Hachijo-kojima Is., Japan).414 The 
configurations  of these unusual sulfonated long chain aromatic alkaloids, potent 
inhibitors of yeast α-glucosidase, were determined from a combination of chemical 
degradation and modified Mosher’s method. A series of bromotyrosine alkaloids, the 
purpurealidins A–H 348–355, were reported from a Psammaplysilla purpurea (India).415 
Purpurealidin B 349 was antibacterial. Two potent antagonists of the sarcoplasmic 
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reticulum calcium channel RyR1-FKBP12, the sulfonates 356 and 357, were isolated 
from Ianthella basta (Guam), along with 34-O-sulfatobastadin-9 358.416 A sulfur-
containing nucleoside, hamiguanosinol 359, was obtained from a Mediterranean 
Hamigera hamigera.354 A bromotyrosine oxime that inhibits mycothiol-S-conjugate 
amidase, isolated from an Oceanapia species,417 has been synthesised.418 The same 
molecule was also synthesised independently through a trifluoromethyloxazole 
intermediate.419 A total synthesis of the eurypamides, first isolated from a Palauan 
Microciona eurypa,420 resulted in revised stereochemistry for eurypamide A 360 and 
confirmed the structures of eurypamides B–D.421 Two macrocyclic merosesquiterpenoids, 
likonides A 361 and B 362, were obtained from a Kenyan Hyatella species.422 17-O-
isoprenyldictyoceratin-C 363 was isolated from a Philippine Spongia species.423 An 
amino-merosesquiterpenoid, 5-epi-smenospongorine 364, isolated from Dactylospongia 
elegans (Flores, Indonesia), caused the differentiation of K562 leukemia cells into 
erythrocytes.424 A Papua New Guinean Psammocinia species contained chromarols A–E 
365–369, inactivators of human 15-lipoxygenase through a redox mechanism similar to 
that reported for a range of known meroterpenoids.425 Makassaric acid 370 and subersic 
acid 371, isolated from an Acanthodendrilla species (Sulawesi, Indonesia), were 
inhibitors of MAPKAP kinase 2.426 Petrosia (Strongylophora) corticata (Papua New 
Guinea) contained the anti-invasion active meroditerpenoid strongylophorine-26 372.427 
A series of merosesquiterpenoids from a variety of sponge sources were assessed for 
hemolytic and cytotoxic properties.428 Similarly, a further range of sponge-derived 
merosesquiterpenoids were active as antioxidants.429 Smenospongine, originally isolated 
from a Smenospongia species,430 caused K562 leukemia cells to differentiate into 
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erythrocytes.431 A series of polyprenylated hydroquinones and benzoic acids of sponge 
origin inhibited phosphatase CDC25A.432 Puupehenone, originally isolated from a 
Hawaiian sponge,433 inhibited the differentiation of endothelial cells into tubular 
structures, an important step in angioneogenesis.434 Chloropuupehenone433 has been 
synthesised.435 An aromatic sesquiterpenoid 373 was isolated from a Didiscus species 
(Thailand).436 Stylotella aurantium (Great Barrier Reef) yielded a carbonimidic dichloride 
stylotellane D 374.437 The weakly antibacterial hyrtiosenolides A 375 and B 376 were 
isolated from a Red Sea Hyrtios species.438 The boneratamides A–C were isolated as their 
methyl esters 377–379 from an Indonesian Axynyssa aplysinoides.439 The relative 
stereochemistry of boneratamide A 377 was established by X-ray analysis, while 
boneratamides B 378 and C 379 differ in their relative configurations at either one or 
both of C-18 and C-23. The antimicrobial germacrane sesquiterpenoid 380, and the bis-
urea analogue 381, were obtained from an Axinyssa species (Thailand).440 Two 
sesquiterpene isothiocyanates 382 and 383 were obtained from an Okinawan Stylissa 
species.441 The biosynthesis of the carbonimidic dichloride sesquiterpenoids, the 
stylotellanes A and B, was examined in the producing organism Stylotella aurantium 
(Great Barrier Reef). Feeding experiments with 14C-labeled metabolites established that 
CN, SCN, and farnesyl isothiocyanate were intermediates in the biosynthetic pathway to 
these dichloroimines.442 A total synthesis of hamigeran E,443 from a New Zealand 
Hamigera tarangaensis, has been reported.444 (6R,7S)-7-amino-7,8-dihydro-α-
bisabolene, from a Halichondria species,445 has been synthesised.446 Helianane, isolated 
from Haliclona fascigera,447 was synthesised employing a vacuum thermolytic ring 
expansion step.448 A Kenyan Raspailia species gave two purine alkaloid-derivatised 
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diterpenes asmarines G 384 and H 385 and the diterpenoid barekol 386, together with 
several related known compounds.449 A Raspailia species (Madagascar) produced further 
asmarines, I–K 387–389, and the diterpenoid nosyberkol 390.450 A furanoditerpenoid 
391, and two related norditerpenoids 392 and 393, that inhibit the lyase activity of DNA 
polymerase β, were obtained from an unidentified Dictyoceratid sponge from Papua New 
Guinea.451 A bright yellow encrusting Aplysillid sponge, tentatively identified as 
Aplysilla sulphurea from S. E. Queensland, contained the cytotoxic and nematocidal 
compound chromodorolide C 394, along with the known A and B congeners.452 
Acanthella cavernosa (Philippines) provided 10-formamido-kalihinol F 395 and 15-
formamido-kalihinol F 396, both of which inhibited bacterial folate biosynthesis.453 A 
norgracilane- 397 and three new aplysulphurane-type spongian diterpenoids 398-400 
were isolated from Dendrilla membranosa (South Shetlands, Antarctic),454 and by 
forming complexes between (R) and (S) 2,2,2-trifluoro-1-(9-anthryl)ethanol and the γ-
methylbutenolide of 397 the absolute stereochemistries were established (as drawn). 
Aplysulphurane-type spongian diterpenoids, with antiinflammatory properties, were also 
reported from a New Zealand Chelonaplysilla violacea.455 Two compounds from this 
series, named as pourewic acid A 398 and cadlinolide C 399, were found in both 
collections along with the formate-containing pourewanone 401, methyl pourewate B 
402, 15-methoxypourewic acid B 403, and an inseparable mixture of the 
diastereoisomeric cadlinolides D 404, with relative stereochemistries established as 
drawn. The optical rotation of the New Zealand-derived pourewic acid A, which was 
small, was comparable to but opposite in sign to that reported for the Antarctic sample, 
but the measurements were made in different solvents (CH2Cl2 vs. CHCl3). Further 
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resolution of the absolute stereochemistries will require more rigorous chiroptical 
evaluation of the samples. In contrast, an Anvers Is., Antarctic, collection of Dendrilla 
membranosa yielded the aromatic antimicrobial spongian diterpenoids, membranolides 
B–D 405–407.456 The three diterpenoid isocyanides 408–410, isocyanate 411, and 
isothiocyanate 412 were isolated from the same Okinawan Stylissa species that had 
yielded the previously described isothiocyanate sesquiterpenes 382 and 383.441 All 
metabolites displayed weak cytotoxicity. The biosynthetic origins of the isocyanide and 
isothiocyanate carbon of a variety of sesqui- and diterpenes isolated from Amphimedon 
terpenensis and an Axinyssa species (Great Barrier Reef), have been investigated. For all 
compounds specific incorporation of 14C-thiocyanate was demonstrated.457 A racemic 
synthesis of kalihinol C, first isolated from an Acanthella species,458 has been reported.459 
Three cytotoxic norsesterterpenoids, tasnemoxides A–C 413–415, have been isolated 
from a Red Sea Diacarnus erythraenus.460 An Acanthodendrilla species (Indonesia) 
provided the cytotoxic acantholides A–E 416–420. Acantholide B 417 was 
antimicrobial.461 A Korean Psammocinia species contained three cytotoxic 
sesterterpenoids, psammocinins A1 421, A2 422 and B 423.
462 (6Z)-Neomanoalide-24,25-
diacetate 424 was obtained from a Palauan Luffariella species.463 A Brachiaster species 
(Thailand) yielded the same manoalide congener 424, the (E) isomer 425 and the potently 
antitubercular 12-deacetoxyscalarin-19-acetate 426.464 Five moderately cytotoxic 
sesterterpenoids, three scalaranes 427–429 and two linear furanoterpenoids 430 and 431, 
were obtained from a Korean Smenospongia species.465 Hyrtios erectus (Hainan Is., 
China) contained the linear furanoterpenoid 5,10-dihydroxyfurospinulosine-1 432, two 
formylhyrtiosal congeners 433 and 434, and 12α-O-acetylhyrtiolide 435.466 Stoeba 
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extensa (Japan) gave the cytotoxic furanosesterterpenoid shinsonefuran 436 along with 
halisulfate 7 437.467 The C-8 stereochemistry of halisulfate 7, originally isolated from a 
Coscinoderma species,468 has been revised to that shown on the basis of careful NOE 
analysis.467 A scalarane-type sesterterpenoid 438, and a related oxycyclic congener 439, 
were obtained from a Madagascan Phyllospongia madagascarensis.469 Two different, 
undescribed Madagascan species of Lendenfeldia contained a linear furanoterpenoid 440 
with potent HIV-1 reverse transcriptase inhibitory activity, along with four scalarane-type 
sesterterpenoids 441–444.470 Suberites caminatus (King George Is., Antarctica) contained 
oxaspirosuberitenone 445 and 19-epi-suberitenone 446.471 In an independent study, a 
Suberites species, also collected from King George Is., Antarctica, yielded suberitenones 
C 447 and D 448, and suberiphenol 449.472 Untenospongin B from an Okinawan 
Hippospongia species,473 has antimicrobial activity.474 A structural comparison of the 
PLA2 inhibitory activity of the petrosaspongiolides, isolated from Petroaspongia 
nigra,475 was reported.476 Using bioassay-guided fractionation, heteronemin477 was 
reisolated as a farnesyl transferase inhibitor from Hyrtios reticulata.478 
Cacospongionolide E from Fasciospongia cavernosa479 has been synthesised.480 A 
synthesis of (–)-(18S)-variabilin from Ircinia variabilis481 has been achieved.482 Four 
cytotoxic steroids 450–453 were obtained from Axinella cf. bidderi (Yemen, Indian 
Ocean).483 Phorbas amaranthus (Florida) contained four moderately cytotoxic nor-ring A 
steroids, phorbasterones A–D 454–457 of which 456 and 457 were isolated as C-24 
epimeric mixtures.484 Nakiterpiosin 458 and nakiterpiosinone 459, both potent cytotoxins, 
were obtained from Terpios hoshinota (Okinawa).485 An Italian Cliona nigricans 
produced the potently cytotoxic polychlorinated steroids clionastatins A 460 and B 
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461.486 The C31 steroid, ophirasterol 462, was isolated from a Colombian Topsentia 
ophiraphidites.487 Two steroidal saponins, erylosides K 463 and L 464, were isolated 
from a Jordanian specimen of the same sponge, Erylus lendenfeldi, from which eryloside 
A was originally isolated.488,489 Rhabdastrella aff. distincta (Hainan Is., China) provided 
four isomalabaricane-type triterpenoids isogeoditins A 465 and B 466, 13-(E)-isogeoditin 




There was a slight increase in new chemistry identified from coelenterates in 2004 
compared to the number reported in 2003. The glycerol derivative 469 was reported from 
a gorgonian Junceella juncea (South China Sea).491 The acyl glycerol ethers 470 and 471 
and ceramide 472 were isolated from a Lobophytum species (Indian Ocean).492 The 
stereochemical assignment of 472 was achieved by analysis of derivatives of hydrolysis 
products. The sphingosines 473 and 474 were obtained as mildly antibacterial 
components of an Indian Ocean gorgonian Pseudopterogorgia australiensis.493 
Structurally-related lipids 475494 and 476495 were isolated from Junceella juncea and a 
Lobophytum species respectively, with stereochemical assignments of 475 being made by 
analysis of hydrolysis products. An Alcyonium species (Senegal) was the source of 
glycolipids 477 and 478.496 The chloromacrolactones, lytophilippines A 479, B 480 and 
C 481, were isolated as bioactive constituents from a Red Sea hydroid Lytocarpus 
philippinus.497 The absolute configuration of 479 was established based upon 
comprehensive derivatisation and chemical degradation studies in concert with J-based 
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analysis and molecular modeling. The moderately cytotoxic pentapeptide 
gymnangiamide 482 was isolated from a Philippines hydroid Gymnangium regae.498 
Chemical degradation and derivatisation, followed by HPLC analysis allowed the 
determination of the absolute configuration of 482. The related clavulazols, A 483 and B 
484, are two new pyrazine derivatives from Clavularia viridis (Taiwan).499 Furanones 
485 and 486 were obtained, in addition to a number of other compounds, from a 
Taiwanese soft coral Sinularia nanolobata.500 The absolute configuration of 485, and by 
association 486, was established by comparison with spectroscopic data previously 
reported for synthetically-derived 485. Prostanoids 487–493 were also isolated from a 
Taiwanese C. viridis.501 The absolute configurations of all compounds were assigned by 
comparison of CD spectra with that for clavulone I. 492 was the most potent cytotoxin in 
the series. The structurally-related punaglandins, originally isolated in 1985 from a 
Hawaiian Telesto riisei,502,503 inhibit ubiquitin isopeptidase activity504 while several 
members of a synthetically-derived library of punaglandin-related analogues exhibited 
similar cytotoxic potency to that observed for the natural product punaglandin 3.505 An 
unusual bicyclic prostanoid, carijenone 494, was obtained from an Eastern Pacific 
octocoral Carijoa multiflora.506 The absolute configuration of (+)-tricycloclavulone 495, 
from an Okinawan Clavularia viridis,507 has been established by enantioselective total 
synthesis.508 The guaiane-skeleton sesquiterpenes menverins A–D 496–499 were isolated 
from Menella verrucosa (South China Sea).509 The instability of the compounds was 
noted, particularly that of 497 which was observed to dehydrate to 500 in the NMR tube 
(CDCl3). Bioassay-guided fractionation of a Taiwanese soft coral Lemnalia cervicorni 
yielded the known mildly cytotoxic sesquiterpene lemnalol as well as the inactive 
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metabolites cervicol 501, isolemnalol 502 and the ketone 503.510 The ketone 503 was 
isomeric with 4-oxo-α-ylangene511 and exhibited identical 13C and NOESY NMR data 
consistent with an α-orientation of the isopropyl group. Sarcophyton glaucum 
(Kitungamwe Reef, Kenya) yielded, in addition to other known compounds, the mildly 
cytotoxic sesquiterpene guaiacophine 504.512 Five nardosinane-skeletoned 
sesquiterpenes, armatins A–E 505–509, were isolated from a Taiwanese Nephthea 
armata.513 Diketone 510 was also reported for the first time as a natural product. Isis 
hippuris (coast of Taiwan) was the source of isishippuric acids A 511 and B 512.514 
Sesquiterpene 512 exhibited moderate in vitro cytotoxicity towards tumour cell lines. 
Cladidiol 513, a mild inhibitor of acetylcholinesterase, was obtained from a Cladiella 
species (Andaman Is., India).515 Sesquiterpenes 514–517 were isolated from Clavularia 
koellikeri (Okinawa).516 Mosher's method secured the absolute stereochemistry of 515, 
which on acetylation gave 514 securing the absolute configuration of this compound as 
well. The absolute configuration of 517, previously reported as a synthetic intermediate, 
516 followed from comparison of the [α]D with literature values.
516 (+)-Cyclocolorenone 
518, previously known as a terrestrial metabolite, and the 1α-OH analogue 519 were 
isolated from a soft coral Nephthea species (Andaman and Nicobar Islands, Indian 
Ocean).517 Nanonorcaryophyllenes A 520 and B 521 were obtained from Sinularia 
nanolobata (Taiwan).500 The absolute configuration of 520 was the opposite of a 
stereochemically-defined microbially-derived metabolite of caryophyllene. The structure 
of the sesquiterpene alcyopterosin N, from the sub-Antarctic soft coral Alcyonium 
paessleri,518 has been confirmed by total synthesis.519 Nine meroditerpenoids, 
chabrolonaphthoquinone A 522, chabrolohydroxybenzoquinones A–D 523–526, and 
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chabrolobenzoquinones A–D 527–530, were isolated from a Taiwanese Nephthea 
chabrolii.520 The merosesquiterpene 531, previously reported as a synthetic 
intermediate,521 has been obtained from a Scleronephthya species (South China Sea).522 
Three publications in 2004, presenting new pterosin diterpene glycosides from the soft 
coral Pseudopterogorgia elisabethae, unfortunately led to duplication in structures and 
trivial names. Ata et al. reported structures of pseudopterosins P 532 and Q 533 in 
addition to elisabethins E 534 and F 535 from P. elisabethae (Bahamas).523 Hydrolysis 
and comparison of optical rotation data supported the presence of β-L-xylose in both 532 
and 533. Both pseudopterosin P and Q, as well as previously reported analogues 
pseudopterosins A–E and K isolated from the same soft coral specimens, exhibited 
antibacterial activity towards Gram-positive bacteria, but not towards Gram-negative 
organisms. Elisabethins E 534 and F 535 were inactive in the same assays. Working with 
P. elisabethae (Colombian Caribbean), Duque et al. isolated seven diterpene glycosides, 
pseudopterosins P–V 536–542.524 The absolute configuration of the aglycone of 536 was 
established by phenolic O-benzylation at C-9, sugar removal by hydrolysis and 
comparison of NMR and chiroptical data reported for the known benzyl ether. In the case 
of 536–539, the sugar was identified as an appropriately acetylated α-L-fucopyranoside 
by hydrolysis, derivatisation and chromatographic analysis, while β-D-arabinopyranoside 
was the sugar moiety present in 540–542. The structures presented for pseudopterosins U 
541 and V 542 are isomeric with those previously reported for pseudopterosins O and N 
respectively.525 Confusingly, in the original publication that reported pseudopterosins N 
and O,525 the structures were drawn as bearing xyloside sugar moieties, while the text 
suggested the structures contained D-arabinose sugars. The NMR data reported for 
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pseudopterosins U and V are not coincident with the values previously reported for 
pseudopterosins O and N. Rodriguez et al., also working with P. elisabethae (Colombian 
Caribbean), isolated eleven diterpene glycosides that they named pseudopterosins P 537, 
Q 538, R 543, S 544, T 536, U–Z 545–550, and two seco-pseudopterosins, H 551 and I 
552.526 The absolute configuration of the sugars in 551 and 552 were not determined – 
they are arbitrarily represented in this review as D. Of the metabolites reported by 
Rodriguez et al., 543 and 544 represent unique diacetate derivatives. Whereas Duque et 
al. reported 540–542 claiming the presence of a β-D-arabinose sugar, Rodriguez et al. 
reported the apparently isomeric structures 549, 545 and 546 respectively as containing 
an α-D-arabinoside moiety, together with 547 and 548, also containing this moiety. The 
NMR and optical rotation data reported for the α-/β- anomer pairs 541/545 and 542/546 
were identical (but different to pseudopterosins N and O, see above), indicating a lack of 
congruity between the structures and their stereochemistries. As of October 2005 these 
issues had not been addressed and resolved in the scientific literature. Diterpenes 537, 
538, 545–548, 551 and 552 displayed activity in a number of biological assays including 
antiinflammatory, cytotoxicity and antiinfective evaluation.524,526 The relative 
stereochemistry of the cubitane-skeleton diterpene 553, from Eunicea laciniata 
(Barbados), was determined by use of a T-ROESY NMR experiment.527 Cembranes 7,8-
dihydroflabellatene A 554 and B 555 were isolated from extracts of a sea pen 
Gyrophyllum sibogae (South Africa).528 The relative stereochemistry of 554 was secured 
by X-ray analysis (Mosher's method failed), while the absolute configurations of 554 and 
555 were equated to those of the known sponge metabolites 556 and 557.529 Cembrane 
554 exhibited potent antiproliferative activity towards tumour cell lines. Sarcophydiol 
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558 was isolated from a Sarcophyton species (Hainan Is., China).530 Cembradienes 559–
563 were obtained from a Eunicea species (Colombian Caribbean).531 The structure and 
relative configuration of 559 was established by X-ray analysis, confirming that 559–562 
contained the unusual C2-C12 ether linkage, while the inter-relationships between 559–
562 were established by chemical conversion. Mild growth inhibition of Plasmodium 
falciparum was observed for 559, 560 and 562. Of three norditerpenoids, scabrolides E–
G 564–566, from a Taiwanese Sinularia scabra, 564 was a modestly potent growth 
inhibitor against two tumour cell lines.532 Cembratrienes 567 and 568, containing the rare 
(12Z) geometry, were isolated from a new species of Sarcophyton (Great Barrier Reef).533 
The same study also led to the determination of the absolute configuration (MPA ester) of 
sarcoglaucol-16-one 569534 and, by comparison of CD spectra, sarcophine 570.535 The 
acetate derivative 571, also present in a Kenyan Sarcophyton glaucum, was identified as 
a natural product.512 A number of rearranged and halogenated semisynthetic derivatives 
of sarcophine have been prepared and evaluated in a range of biological assays.536,537 
Neodolabellan-skeleton diterpenes 572 and the modestly cytotoxic 573 were isolated 
from an Okinawan soft coral Clavularia koellikeri.516 The structure and relative 
stereochemistry of 572 were established by X-ray analysis, while oxidation of 573 
yielded 572. The absolute configuration of 573, and hence of 572, was secured 
(Mosher's). Nanolobatins A–C 574–576 were reported from Sinularia nanolobata 
(Taiwan).500 All three diterpenes exhibited modest cytotoxicity towards tumour cell lines. 
The structure and relative configuration of ciereszkolide 577, a rearranged cembrane 
from a Caribbean sea plume Pseudopterogorgia kallos, was established by X-ray 
analysis.538 Further examination of the same species from the same location also afforded 
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the hexacyclic diterpene, bielschowskysin 578, secured by X-ray analysis.539 Modest 
biological activity towards Plasmodium falciparum and human tumour cell lines was 
observed. A number of new briarane-skeleton diterpenes were isolated from coelenterates 
in 2004. Fragilide A 579540 and junceellolide I 580541 were obtained in separate studies 
from the same collection of Junceella fragilis (southern coast of Taiwan). Another 
collection of J. fragilis, this time from the South China Sea, afforded junceellonoids A 
581 and B 582,542 while extracts of J. juncea, (also South China Sea) yielded juncins O–
Q 583–585.543 Briaexcavatolides W 586,544 and X–Z 587–589,545 were obtained from a 
Taiwanese Briareum excavatum. A sea whip Ellisella species (Okinawa) was the source 
of briaranes 590–593, of which 591 and 592 were inhibitors of cytokinesis.546 The same 
paper also reported 594–597 and a number of known diterpenes from a sea pen Pteroides 
species (Indonesia). One of the known diterpenes, 12-O-desacetyl-12-O-
benzoylpteroidine,547 demonstrated in vitro reversal of multi-drug resistance properties. 
The absolute stereochemistry of minabein-4 598 was established by X-ray analysis.548 
From this it was concluded that the C-2/C-9 diastereomeric structure reported for nui-
inoalide-D, isolated from Junceella gemmacea,549 which exhibits identical 13C NMR data 
to 598, was incorrect. Kitungolides A–C 599–601 are unusual coumarin-containing 
diterpenes from a new genus of Kenyan soft coral.550 Pregnanes 602 and 603, previously 
reported as synthetic intermediates,551,552 were isolated from a Scleronephthya species 
(South China Sea).522 The Δ20-pregnanes 604 and 605, from an Indopacific Carijoa 
species, were identified as moderately potent inhibitors of the mitochondrial respiratory 
chain.553 Carijoa multiflora (Panama) gave the unusual chlorinated pregnanes 606 and 
607.554 Pregnane 608, previously known as a synthetic intermediate,555 and the diacetoxy-
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analogue 609 were isolated from a Taiwanese Subergorgia mollis.556 The pregnane 
saponin 610, from a Panamanian Muricea cf purpurea, is unusual because it contains L-
galactose linked to the aglycone by an α-glycosidic bond.557 The sugar configuration was 
determined by hydrolysis, derivatisation and comparison of CD spectra with the 
corresponding synthetically-prepared α-D and β-D-galactose derivatives. Interestingly, a 
saponin bearing the same overall structure and comparable [α]D value, but with a β-
glycosidic linkage 611, was reported from Eunicea laciniata (Barbados).527 The natural 
product 612 was isolated from a Lobophytum species (Andaman and Nicobar Islands),558 
while the 19-hydroxylated steroids acanthovagasteroids A–D 613–616 were reported 
from Acanthogorgia vagae (South China Sea).559 The 19-acetoxysterols armatinols A 617 
and B 618 were isolated as mildly cytotoxic components from a Taiwanese Nephthea 
armata.513 Two new, 619 and 620, and three known sterols were obtained from 
Sarcophyton glaucum (Taiwan).560 Whilst 619 and 620 were inactive, two of the known 
sterols exhibited modest cytotoxicity towards a panel of mouse and human tumour cell 
lines. The modestly cytotoxic steroids 621–627 were isolated from an Antarctic octocoral 
Dasystenella acanthina.561 The absolute configuration at C-24 in 621 was established 
(Mosher's). Bioassay-directed fractionation of extracts of Dendronephthya gigantea 
(Green Is., Taiwan) yielded dendronesterones A–C 628–630 of which 628 exhibited mild 
cytotoxicity.510 In addition to the diterpenes reported above, the cholic acid derivatives 
631and 632 were obtained from an Eleutherobia species (Pohnpei, Micronesia).548 The 
structure of the first A-nor-hippuristanol steroid 633, a mildly cytotoxic constituent of a 
Taiwanese Isis hippuris, was established by X-ray analysis.514 Steroidal glycoside 634 
was isolated from Junceella juncea (South China Sea).491 The structure of 24-methylene-
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cholesta-3β,5α,6β,19-tetraol, a mildly cytotoxic sterol from Nephthea albida and N. 
tiexieral verseveldt,562 has been confirmed by synthesis from stigmasterol.563 A number 
of steroids, from a range of coelenterates, exhibited significant inhibition of the 5α-
reductase enzyme.564 The structures of three mildly cytotoxic biscembranoids, methyl 
tortuoates A 635 and B 636 from Sarcophyton tortuosum (Hainan Is.),565 and nyalolide 
637, from a Kenyan Sarcophyton glaucum,512 were established by X-ray analyses of 635 
and 637. The structures of all three are arbitrarily presented in this review as bearing the 
purported absolute configuration of the related metabolite methyl sartortuoate.566 Two 
unusual mixed-skeleton terpenoids were also reported from soft corals in 2004. 
Stolonilactone 638, putatively derived from condensation of a cembrane diterpenoid and 
trisnorsesquiterpene fragments, was obtained from an Okinawan Clavularia koellikeri.567 
The structure of polymaxenolide 639, from a hybrid soft coral Sinularia maxima x S. 
polydactyla (Guam), was established by X-ray analysis,568 and represents the fusion of a 




The number of new secondary metabolites reported from bryozoans in 2004 remains 
small. Six alkaloids, calibugulones A-F 640–645, were isolated from Calibugula intermis 
(Palau) with the structures of 641 and 642 being confirmed by chemical interconversion. 
All calibugulones displayed cytotoxicity against murine IC-2WT tumour cells in vitro with 
644 being the most potent.569 Two syntheses of calibugulones employing similar methods 
from an isoquinoline dione,570 or 5-aminoisoquinoline571 were reported almost 
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simultaneously. The potent and selective inhibition of the dual specificity phosphatase 
Cdc25B was also reported for these compounds.570 Larvae of Bugula neritina (Morehead, 
North Carolina) were the source of bryostatin 20 646, along with the known bryostatin 
10572 and an as yet uncharacterised bryostatin.573 Proof that Endobugula sertula, the 
bacterial symbiont of Bugula neritina, is the producer of the bryostatins was recently 
obtained.574 The bryostatins are concentrated in the bryozoan larvae and give protection 
against predation by fish, but the adults are unprotected. The bryostatins represent the 
first marine example of a microbial symbiont producing an antipredator defense for its 
host.574 Flustra foliacea (“Steingrund”, North Sea) was the source of 
deformylflustrabromine B 647 along with a number of previously reported compounds. 
All compounds were tested in vitro for affinity towards the α4β2* and α7* subtype of the 
neuronal nicotinic acetylcholine receptor using radioligand binding assays, with 
deformylflustrabromine575 and deformylflustrabromine B 647 showing affinities in the 
lower micromolar range.576 Myriaporones are polyketide-derived compounds originally 
isolated from a bryozoan Myriapora truncata.577,578 The total syntheses of myriaporones 
1 648, 3 649 and 4 650 have been reported by two groups allowing determination of the 
previously undetermined C-5 and C-6 configurations.579,580 The first enantioselective 
synthesis of the Flustra foliacea metabolite (–)-flustramine B581 has been accomplished, 





There was a decrease in new chemistry identified from molluscs in 2004. Bioassay-
directed fractionation of extracts from Mytilus galloprovincialis (coast of Italy) afforded 
the cytotoxic chlorosulfolipid 651.583 The relative configurations were deduced from 
NMR data, while the absolute configuration was based upon comparison with related 
compounds from the same source. Collections of Mytilus edulis and Cerastoderma edule 
in the presence of a Dinophysis acuta bloom (coast of Norway) afforded PTX-12 652, a 
new member of the pectenotoxin family that occurs as a pair of C-36 equilibrating 
diastereoisomers.584 A brevetoxin analogue, brevetoxin B5 653, was isolated from a New 
Zealand cockle Austrovenus stutchburyi and also detected in two other mollusc species, 
Perna canaliculus and Crassostrea gigas.585 The structure was elucidated by comparison 
with related toxins brevetoxin B1 and PbTx-2 and confirmed by chemical conversion 
from PbTx-2. A sea hare Dolabella auricularia (Japan) afforded the cytotoxic 
depsipeptide aurilide 654.586 The absolute stereochemistry of 654 was determined by 
analysis of hydrolysis products and confirmed by enantioselective synthesis. Aurilide 
exhibits potent in vitro cytotoxicity, toxicity in in vivo evaluation and strongly stabilises 
microtubules, but with a different mechanism from that exhibited by taxol. The relative 
stereochemistry was established for the cytotoxic glycosidic macrolide dolastatin 19 655 
from D. auricularia (Gulf of California).587 It has been demonstrated that mate attraction 
in sea hares of the genus Aplysia is mediated via attractin peptides that contain a 
conserved Ile-Glu-Glu-Cys-Lys-Thr-Ser heptapeptide sequence.588 Haterumaimides L 
656 and M 657 and 3β-hydroxychlorolissoclimide 658 were obtained as cytotoxic 
components from Pleurobranchus albiguttatus and P. forskalii (Philippines).589 
Structurally-related chlorinated diterpenes have been reported previously from 
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Lissoclinum ascidians,590,591 supporting the assertion that the mollusc compounds are 
diet-derived. The isolation of a number of scalarane-skeleton metabolites, including 659 
and 660 from a nudibranch Glossodoris rufomarginata (South China Sea), was proposed 
to be dietary-linked as the nudibranchs were found on an unidentified sponge which 
contained scalaradial.592 Tribromoimidazole 661 was reported for the first time as an 
antimicrobial natural product from the egg masses of Spanish and Chilean collections of 
Trunculariopsis trunculus, Ceratosoma erinaceum and Trophon geversianus, with the 
structure confirmed by synthesis.593 Sesquiterpenes 662–664 were isolated from a 
nudibranch Phyllidiella pustulosa, (Hainan Is., South China Sea).594 The absolute 
configuration of 662 was established by chemical conversion to a known diene. The 
absolute stereochemistry of oxazinin-3 665, from North Adriatic Sea mussels,595 was 
established by synthesis,596 while the structure and absolute stereochemistry of 
azaspiracid-1 666, originally obtained from Irish collections of Mytilus edulis,597 has been 
revised as a consequence of stereoselective total synthesis.598,599 The structure of 
cyercene A, a pyrone polypropionate from a Mediterranean Cyerce cristallina,600 has 
been confirmed by synthesis.601 Austrodoric acid 667, from an Antarctic nudibranch 
Austrodoris kerguelenensis,602 has been synthesised with comparison of CD spectra being 
used to establish the absolute configuration of the natural product.603 The structure 
proposed for onchidin,604 a cytotoxic depsipeptide from a pulmonate Onchidium species 
but possibly of cyanobacterial origin, has been synthesised and exhibited different 
spectroscopic data to that observed for the natural product.605 A full account of the 
stereoselective synthesis of (+)-brasilenyne, an antifeedant haloether from a sea hare 
Aplysia brasiliana,264 has been reported.266 Enantioselective syntheses of (–)-tochuinyl 
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acetate 668 and (–)-dihydrotochuinyl acetate 669606 defined the absolute configurations 
of the sesquiterpenes that were isolated from a nudibranch Tochuina tetraquetra and its 
dietary soft coral Gersemia rubiformis.607 Dolastatin 18 670, from Dolabella 
auricularia,608 has been synthesized, confirming the original (R) stereochemistry of the 
N-Me-Phe unit.609 The absolute configuration of ulapualide A 671, the renowned 
bioactive macrolide from egg masses of a nudibranch Hexabranchus sanguineus,610 has 
been solved by X-ray analysis of a complex with G-actin.611 The sponge metabolite 
renieramycin M can be converted to jorumycin 672,612 a cytotoxic isoquinoline alkaloid 
comparable in potency to ecteinascidin 743, which was originally isolated from a 
nudibranch Jorunna funebris (Mandapam, India).613 The absolute configuration of (+)-
norrisolide 673, from a nudibranch Chromodoris norrisi,614 has been established by 
stereoselective synthesis,615 while the biogenetically-proposed stereoisomer of 
acanthodoral 674, from a nudibranch Acanthodoris nanaimoensis,616 has also been 
synthesised.617 The de novo biosynthesis of aglajnes-1 and -3, linear and 4-hydroxy-α-
pyrone polypropionate metabolites previously isolated from opistobranch molluscs 
Aglaja depicta618 and Bulla striata619 respectively, has been established by [1-14C]-
propionate feeding experiments.620 Cell-free preparations of Oxynoe olivacea can convert 
the dietary algal metabolite caulerpenyne621 into oxytoxin-2,622 the main defensive 
metabolite of the mollusc.623 The biosynthesis of 3-alkylpyridine alkaloids haminol-1 and 
-2, from a Mediterranean Haminoea orbignyana,624 has been studied using [1,2-13C2]-
acetate incorporation, establishing elongation with acetate of a nicotinic acid starter 
unit.625 Parguerol and isoparguerol, originally from Aplysia dactylomela,626 induced 
neurite outgrowth in PC-12 cells with modest potency.627 The shellfish biotoxin 
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yessotoxin192 was a potent opener of the permeability transition pore on inner 
mitochondrial membranes.193  
 
11 Tunicates (ascidians) 
 
While the number of new metabolites isolated from ascidians has remained essentially 
static for each of 2002 and 2003, a slight decrease was reported in 2004. As with previous 
years, the majority of the metabolites reported from ascidians are derived from amino 
acids. (2S,3R)-2-Aminododecan-3-ol 675 was reported as an antifungal component of 
Clavelina oblonga (Brazil).628 The absolute stereochemistry was secured by preparation 
of the dibenzoyl derivative and comparison of CD data with structurally-defined model 
compounds. The first examples of acetylenic lipids from an organism of the phylum 
Chordata 676–679 were isolated from an unidentified ascidian of the family Polyclinidae 
(Spain).629 Biselides A 680 and B 681 were obtained from an Okinawan ascidian from 
the family Didemnidae.630 Absolute stereochemistry was implied by comparison of NMR 
and CD data with those reported for the corrected absolute configuration of haterumalide 
NA.631,632 A stereoselective total synthesis633 has confirmed the structure and absolute 
configuration of bistramide A 682 from Lissoclinum bistratum.634 The absolute 
configurations of lepadins D635 683, E635 684 and H636 685, from a Didemnum species635 
and Aplidium tabascum,636 have been ascertained by stereoselective total synthesis.637 
1,3-Dimethyl-8-oxoisoguanine 686 was isolated from an ascidian Pseudodistoma cereum 
(New Zealand).638 An Australian Atriolum robustum was the source of amino acid-
derived metabolites 687–691.639 The absolute stereochemistries of 687 and 688 were 
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established by degradative derivatisation studies while only the relative configurations of 
methylthioadenosine analogues 690 and 691 were determined. Compound 690 was a 
relatively potent partial agonist of human A3 adenosine receptors. A Palaun Botrylloides 
tyreum afforded the weakly cytotoxic tyrosine analogues botryllamides E–H 692–695.640 
Cystodytes cf. violatinctus (Kenya) gave violatinctamine 696, which in solution was 
proposed to exist as a rapidly interconverting mixture of imino-phenol (shown) and 
amino quinone-methide tautomers.641 Lissoclibadin 1 697 was isolated as a mildly 
antibacterial component of an Indonesian Lissoclinum cf. badium.642 The relative 
orientations of the aromatic rings were based upon molecular modelling studies. 
Fascaplysin analogues 301 and 698–701 were obtained from a Didemnum species (Chuuk 
Atoll, Micronesia), while 301 was also isolated from a sponge Fascaplysinopsis 
reticulata (Fiji).376 Asymmetric syntheses of (+)-arborescidine A, (–)-arborescidine B and 
(–)-arborescidine C, antipodes of the natural products 702–704 from a New Caledonian 
Pseudodistoma arborescens,643 have been achieved via use of the Noyori catalytic 
asymmetric hydrogen transfer reaction.644 The synthetic arborescidines had opposite 
optical rotations to those of the natural products, establishing the absolute configurations 
as drawn and claimed originally,643 but opposite to those claimed in a subsequent 
revision.645 Three lamellarin alkaloids, lamellarins γ 705, α 706 and ε 707 were reported 
from Didemnum obscurum (Indian Ocean),646 while solid-phase syntheses of lamellarins 
Q and O have been reported.647 Four further ecteinascidins, ETs 731 708, 745b 709, 808 
710 and 815 711 from Ecteinascidia turbinata were disclosed in a patent.648 Full accounts 
of the biomimetic synthesis of the dimeric prenylated quinone (–)-longithorone A649 from 
Aplidium longithorax,650,651 of the corrected structure of diazonamide A,652 and the 
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isolation and synthesis of an endogenous sperm-activating and attracting factor from 
Ciona intestinalis653 have been reported. The structures of cyclic peptides bistratamides 
E, G and J,654,655 from Lissoclinum bistratum,656 botryllazine B,657 from a Spanish 
Botryllus leachi,658 and subarine,659 a potentially ring-opened pyridoacridine alkaloid 
from an unidentified Singaporean ascidian,660 have been confirmed by syntheses. 
Molecular dynamics simulations have modelled the interaction of didemnins A and 
B661,662 with human elongation factor eEF1A in the presence of GTP, an interaction that 
leads to inhibition of protein synthesis.663 Monomeric analogues of the heterodimeric 
antimicrobial peptide halocidin from Halocynthia aurantium664 have been prepared, 
leading to the identification of a more potent antimicrobial and less haemolytic variant.665 
Further biological investigation of the meridianins, aminopyrimidineindole alkaloids 
originally from Aplidium meridianum,666 has revealed that they inhibit various protein 
kinases, prevent cell proliferation and induce apoptosis,667 while polycarpine, an alkaloid 
from Polycarpa clavata,668 and a dimethyl analogue both induced apoptosis via p53 and 




There was a slight increase in new compounds identified from echinoderms in 2004 
compared to 2003. In addition to a number of known metabolites, xanthosine 712 was 
isolated from a starfish Asterias rollestoni (Yellow Sea, China).670 A ganglioside 
molecular assemblage, LMG-4, the major entity of which is represented by 713, was 
obtained from a Japanese starfish Luidia maculata.671 The ganglioside displayed 
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neuritogenic activity against PC12 cells in the presence of nerve growth factor. A 
structurally more complex ganglioside molecular entity CJP4 714, also exhibiting 
neuritogenic activity, was isolated from a Japanese feather star Comanthus japonica.672 
The progesterone derivative 715 was obtained from a Russian starfish Lethasterias 
nanimensis chelifera,673 while the polyhydroxysterol 716 was isolated from a Pacific 
starfish Asterina pectinifera.674 Brine shrimp assay-directed fractionation of a starfish 
Certonardoa semiregularis, (Komun Is., Korea) extract, afforded twelve 
polyhydroxysterols 717–728 and two saponins 729 and 730.675 Side-chain configurations 
were determined either by Mosher analysis (certonardosterols Q2 718, A3 725, A4 726, B4 
727 and certonardoside H4 730) or biogenetic arguments (certonardosterols Q1 717, Q3 
719, Q4 720, Q5 721, Q6 722, Q7 723, D5 728 and certonardoside H3 729). All of the 
compounds tested exhibited modest in vitro cytotoxicity towards a panel of human 
tumour cell lines. In a separate study of the same organism from the same location, a 
further eleven sterols 731–741 and eight saponins 742–749 were identified.676 A 
glycoside, phrygioside A 750 and the corresponding aglycone 751, were isolated from a 
starfish Hippasteria phrygiana (Sea of Okhotsk).677 The steroid-taurine conjugate, 
triseramide 752, was a mildly bioactive component of a Fijian starfish Astropecten 
triseriatus.678 The Far-Eastern starfish Henricia sanguinolenta and H. leviuscula 
leviuscula yielded the saponins sanguinosides A 753 and B 754.679 The C-24 
configuration of 754 was based on biogenetic considerations. Further investigation of the 
side-chain absolute stereochemistries of henriciosides H1 755, H2 756 and H3 757, 
originally isolated from a Far-Eastern starfish H. derjugini,680 (Mosher's) established that 
755 is, in fact, identical to the previously reported steroid laevisculoside I,681 and that 756 
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has the (24R,25S) configuration while 757 is (24R,25R).682 Linckosides C–E 758–760, 
from the Okinawan starfish Linckia laevigata, induced neurite outgrowth in PC12 
cells.683 The relative configurations of C-24 and C-28 in 759 were established, with the 
same configurations implied for 758. The triterpene aglycones, philinopgenins A–C 761–
763, were obtained from the acid hydrolysate of the crude glycoside fraction from a sea 
cucumber Pentacta quadranglasis (South China Sea).684 The philinopgenins are possibly 
artefacts. Two saponins, thyonosides A 764 and B 765, were isolated from the sea 




Two 21-residue antimicrobial peptides, arenicin-1 766 and arenicin-2 767 were obtained 
from a polychaete worm Arenicola marina (White Sea, Russia).686 Diatom-derived 
conjugated aldehydes such as (2E,4E)-decadienal continue to be of interest, exhibiting 
cytotoxicity towards a number of different organisms including bacteria, algae, fungi, 
echinoderms, molluscs and crustacea687 in addition to inhibiting fertilization success in 
broadcast-spawning invertebrates.688 The structure of the antipredatory chemical defense 
compound 2,3,4-tribromopyrrole from a hemichordate worm Saccoglossus 
kowalevskii,689 has been confirmed by synthesis.690 Mass spectrometric analysis of stable 
isotope incorporation experiments determined that Cypridina luciferin, an alkaloid 
utilised by the bioluminescent crustacean Cypridina (Vargula) hilgendorfii, is 
biosynthesised from L-tryptophan, L-arginine and L-isoleucine.691 Gymnorrhizol 768, an 
unusual macrocyclic polydisulfide possessing an unprecedented carbon skeleton, has 
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been isolated from a mangrove Bruguiera gymnorrhiza (Guangxi Province, China). The 




In this review, the structures of 767 compounds have been reported. The biological 
testing on, or biological properties of, 380 compounds is included. Using numbers 
extracted from MarinLit,79 the geographic origins of compounds reported in 2004 are 
compared with those up to 2003 (Fig. 1a). The geographical descriptors used in MarinLit 
are somewhat imprecise, ranging from exclusive to inclusive, but Australia, the 
Caribbean, the Indian Ocean, Japan, the Mediterranean and the Western Pacific clearly 
stand out as the sources for two-thirds of the reports on marine natural products, with 
Japan being the clear leader. What is most notable about the data for 2004 (Fig. 1b) is the 
marked increase in citations relating to the China Sea. Also shown in Fig. 1 is the relative 
proportion of articles for each region reporting bioactivity (“bioarticles”). These, taken 
collectively, suggest the possibility that greater attention is being paid to searching for, or 
commenting on, bioactive compounds (55% in 2004 vs. 49% up to 2003).  
Insert Figures 1a and 1b 
A second point of comparison is the type of biological activity reported which can 
grouped into eight areas - Anticancer, Antibiotic (which includes antifungal and 
antimalarial), Antiinflammatory, Antiviral, Immunomodulatory, Various, Agricultural 
and Methodology. Fig. 2 shows the types of the testing carried out up to, and including, 
2004.  
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Insert Figure 2 
The actual data for 2004 did not vary significantly from that reported cumulatively, but 
was suggestive that the “catch-all” category of Methodology was increasing. Testing with 
an anticancer outcome remains far and away the most used assay, but increasingly results 
are appearing in the literature for antimalarial, antitubercular and antiinfective assays 
against drug-resistant microorganisms and in time these areas will stand out against the 
cumulative record. There can be no doubt of the urgent need for new therapeutics in those 
areas, but also in agricultural areas where resistance to the standard anthelmintics is 
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